Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

187

Participants

Timeline

Start Date

July 13, 2018

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Breast Cancer
Interventions
OTHER

SAE battery

The SAE battery yields 12 variables.

BEHAVIORAL

Assessments

Assessments of their neurocognitive performance will be assessed longitudinally, at 4 time points: prior to adjuvant treatment (post-surgery); 1 month (with a +4 week window) post-chemotherapy; and again at the 12 and 24 months (with a +4 week window) post-treatment time points. These assessment time points are denoted as T1 though T4, respectively. The assessment schedule for the HC and CT- groups will be yoked against that of the CT+ cohort.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

The City College of New York

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03619083 - Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer | Biotech Hunter | Biotech Hunter